Literature DB >> 20937969

Macrophage migration inhibitory factor in the paraventricular nucleus plays a major role in the sympathoexcitatory response to salt.

Eduardo Colombari1, Debora S A Colombari, Hongwei Li, Peng Shi, Ying Dong, Nan Jiang, Mohan K Raizada, Colin Sumners, David Murphy, Julian F R Paton.   

Abstract

Central hyperosmotic stimulation (HS) evokes increases in sympathetic nerve activity mediated by activation of angiotensin type 1 receptors in the hypothalamic paraventricular nucleus (PVN). Macrophage inhibitory migration factor (MIF) is an intracellular inhibitory regulator of angiotensin type 1 receptor-mediated actions of angiotensin II within neurons of the PVN. MIF mediates its actions via its intrinsic thiol-protein oxidoreductase activity. We demonstrate that intracerebroventricular injection of hypertonic saline into Sprague-Dawley rats elicits a significant (≈112%) increase in MIF mRNA expression in the PVN. Next, we evaluated the effect of viral-mediated expression of either MIF or [C60S]-MIF (which lacks thiol-protein oxidoreductase activity) in the PVN on the sympathoexcitation evoked by HS. We used a decorticate, arterially perfused in situ preparation of male Wistar rats (60 to 80 g). HS was induced by raising perfusate osmolality from 290 to 380 milliosmoles for 40 seconds. Seven to 10 days before experiments, rats were injected bilaterally (500 nL per side) with 0.9% saline (control) or with adenoassociated virus to express MIF, [C60S]-MIF, or enhanced green fluorescent protein in the PVN. HS produced sympathoexcitation in both the 0.9% saline and enhanced green fluorescent protein groups (sympathetic nerve activity increase of +27±4% and +25±4%, respectively; P<0.05), an effect that was not observed in the MIF group (+4±5%). Conversely, the HS-induced increase in sympathetic nerve activity was potentiated in the [C60S]-MIF group (+45±6%; P<0.05). We propose that MIF acting within the PVN is a major counterregulator of HS-induced sympathoexcitation, an effect that depends on thiol-protein oxidoreductase activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937969      PMCID: PMC3130992          DOI: 10.1161/HYPERTENSIONAHA.110.155101

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  35 in total

1.  Hypothalamic paraventricular nucleus and cardiovascular regulation.

Authors:  E Badoer
Journal:  Clin Exp Pharmacol Physiol       Date:  2001 Jan-Feb       Impact factor: 2.557

Review 2.  Forebrain osmotic regulation of the sympathetic nervous system.

Authors:  Sean D Stocker; Jeffrey L Osborn; Samuel P Carmichael
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-12-07       Impact factor: 2.557

3.  Differential effects of intravenous hyperosmotic solutes on drinking latency and c-Fos expression in the circumventricular organs and hypothalamus of the rat.

Authors:  Jacqueline M Ho; Dannielle K Zierath; Anna V Savos; Dominic J Femiano; John E Bassett; Michael J McKinley; Douglas A Fitts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-28       Impact factor: 3.619

4.  AT(1) and glutamatergic receptors in paraventricular nucleus support blood pressure during water deprivation.

Authors:  Korrina L Freeman; Virginia L Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-21       Impact factor: 3.619

5.  Phosphate-activated glutaminase-containing neurons in the rat paraventricular nucleus express angiotensin type 1 receptors.

Authors:  Nan Jiang; Peng Shi; Hongwei Li; Shun Lu; Leah Braseth; Adolfo E Cuadra; Mohan K Raizada; Colin Sumners
Journal:  Hypertension       Date:  2009-08-10       Impact factor: 10.190

Review 6.  The sympathetic control of blood pressure.

Authors:  Patrice G Guyenet
Journal:  Nat Rev Neurosci       Date:  2006-05       Impact factor: 34.870

7.  Macrophage migration inhibitory factor: an intracellular inhibitor of angiotensin II-induced increases in neuronal activity.

Authors:  Chengwen Sun; Hongwei Li; Lin Leng; Mohan K Raizada; Richard Bucala; Colin Sumners
Journal:  J Neurosci       Date:  2004-11-03       Impact factor: 6.167

8.  AT(1)-receptor blockade in the hypothalamic PVN reduces central hyperosmolality-induced renal sympathoexcitation.

Authors:  Q H Chen; G M Toney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-12       Impact factor: 3.619

9.  Vagal afferent input alters the discharge of osmotic and ANG II-responsive median preoptic neurons projecting to the hypothalamic paraventricular nucleus.

Authors:  Sean D Stocker; Glenn M Toney
Journal:  Brain Res       Date:  2006-12-11       Impact factor: 3.252

Review 10.  Central osmotic regulation of sympathetic nerve activity.

Authors:  G M Toney; Q H Chen; M J Cato; S D Stocker
Journal:  Acta Physiol Scand       Date:  2003-01
View more
  12 in total

1.  Increased Expression of Macrophage Migration Inhibitory Factor in the Nucleus of the Solitary Tract Attenuates Renovascular Hypertension in Rats.

Authors:  Rafaela Moreira Barbosa; Guilherme F Speretta; Daniel Penteado Martins Dias; Prashant Jay Ruchaya; Hongwei Li; José Vanderlei Menani; Colin Sumners; Eduardo Colombari; Débora S A Colombari
Journal:  Am J Hypertens       Date:  2017-04-01       Impact factor: 2.689

2.  Macrophage migration inhibitory factor in the nucleus of solitary tract decreases blood pressure in SHRs.

Authors:  André Henrique Freiria-Oliveira; Graziela Torres Blanch; Hongwei Li; Eduardo Colombari; Débora Simões Almeida Colombari; Colin Sumners
Journal:  Cardiovasc Res       Date:  2012-09-20       Impact factor: 10.787

3.  Novel mechanism within the paraventricular nucleus reduces both blood pressure and hypothalamic pituitary-adrenal axis responses to acute stress.

Authors:  Benedek Erdos; Rebekah R Clifton; Meng Liu; Hongwei Li; Michael L McCowan; Colin Sumners; Deborah A Scheuer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

Review 4.  Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension.

Authors:  Jasenka Zubcevic; Hidefumi Waki; Mohan K Raizada; Julian F R Paton
Journal:  Hypertension       Date:  2011-05-02       Impact factor: 10.190

5.  Activation of the hypothalamic paraventricular nucleus by forebrain hypertonicity selectively increases tonic vasomotor sympathetic nerve activity.

Authors:  Walter W Holbein; Glenn M Toney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-17       Impact factor: 3.619

6.  Switching control of sympathetic activity from forebrain to hindbrain in chronic dehydration.

Authors:  Débora S A Colombari; Eduardo Colombari; Andre H Freiria-Oliveira; Vagner R Antunes; Song T Yao; Charles Hindmarch; Alastair V Ferguson; Mark Fry; David Murphy; Julian F R Paton
Journal:  J Physiol       Date:  2011-06-27       Impact factor: 5.182

7.  Inhibition of BDNF signaling in the paraventricular nucleus of the hypothalamus lowers acute stress-induced pressor responses.

Authors:  Chris L Schaich; Theresa L Wellman; Zachary Einwag; Richard A Dutko; Benedek Erdos
Journal:  J Neurophysiol       Date:  2018-04-25       Impact factor: 2.714

8.  Carotid bodies contribute to sympathoexcitation induced by acute salt overload.

Authors:  Elaine Fernanda da Silva; Mirian Bassi; José Vanderlei Menani; Débora Simões Almeida Colombari; Daniel Breseghello Zoccal; Gustavo Rodrigues Pedrino; Eduardo Colombari
Journal:  Exp Physiol       Date:  2018-11-10       Impact factor: 2.969

9.  Systemic leukotriene B4 receptor antagonism lowers arterial blood pressure and improves autonomic function in the spontaneously hypertensive rat.

Authors:  Paul J Marvar; Emma B Hendy; Thomas D Cruise; Dawid Walas; Danielle DeCicco; Rajanikanth Vadigepalli; James S Schwaber; Hidefumi Waki; David Murphy; Julian F R Paton
Journal:  J Physiol       Date:  2016-07-08       Impact factor: 5.182

10.  Sympathetic overactivity occurs before hypertension in the two-kidney, one-clip model.

Authors:  Elizabeth B Oliveira-Sales; Eduardo Colombari; Ana Paula Abdala; Ruy R Campos; Julian F R Paton
Journal:  Exp Physiol       Date:  2015-12-14       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.